By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:




Affinimark Technologies Inc. 

Company News
Biocryst (BCRX) Reports First Quarter 2017 Financial Results 5/4/2017 11:50:46 AM
Biocryst (BCRX) To Announce First Quarter 2017 Financial Results May 4 4/25/2017 9:51:28 AM
Biocryst (BCRX) Expands Development Of BCX7353 To Explore Treatment Of Acute HAE Attacks 4/12/2017 10:26:12 AM
Biocryst (BCRX) Prices Public Offering Of Common Stock 3/10/2017 10:02:10 AM
Biocryst (BCRX) Reports Positive Interim Results From Its APeX-1 Trial 2/27/2017 8:14:58 AM
Biocryst (BCRX) Reports Fourth Quarter And Full Year 2016 Financial Results 2/27/2017 8:11:42 AM
Why Biocryst (BCRX) Is A High-Risk High-Reward Stock 2/20/2017 6:21:26 AM
Biocryst (BCRX) To Announce Fourth Quarter And Year End 2016 Financial Results February 27 2/15/2017 8:19:42 AM
Biocryst (BCRX) Announces The Acceptance Of Peramivir MAA Filing By The EMA 1/30/2017 7:51:12 AM
Biocryst (BCRX) Receives Health Canada Approval For RAPIVABĀ® For The Treatment Of Influenza 1/9/2017 7:23:20 AM